ANDA 201484, held by Watson Labs Inc. Levofloxacin.
As of Nov 16, 2026, ANDA 201484 (Levofloxacin), held by Watson Labs Inc, was first approved by FDA on Nov 22, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 22, 2013 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters